Download highlights from our latest eBook when you complete the form below.

In this eBook, we delve further into the cell therapy workflow and highlight the patient as a focal point throughout this journey. We also explore how a GMP-compliant, semiautomated manufacturing platform can result in consistent, efficacious CAR T cell production.

Contents include:

  • [FOREWORD] Welcome to our eBook on ‘Cell therapy: optimizing the vein-to-vein workflow’
  • [INTERVIEW] From vendor to cell therapy partner: an interview with Xavier de Mollerat du Jeu, Thermo Fisher Scientific
  • [APPLICATION NOTE] Autologous CAR T cell manufacturing using a semiautomatic, closed, modular workflow
  • [INFOGRAPHIC] Cell therapy workflow: integrated solutions from collection to delivery
  • [CELL THERAPY HANDBOOK]
    • Raw material considerations for cell therapy manufacturing
    • Cell therapy vendor qualification process
  • [PERSPECTIVE] Improved harmonization of critical characterization assays across cell therapies
  • [COMMENTARY] Development of a closed and automated bioreactor technology for cell therapy manufacturing – a sharing of our journey
Thermo cell therapy eBook cover snippet

 

RegMedNet registration